Company Says Its Experimental Antibody Treatment Reduced Hospitalization Among Patients With Moderate COVID-19

September 17, 2020

Reuters (9/16, Beasley) reports Eli Lilly “said on Wednesday interim trial data showed its experimental antibody treatment reduced the need for hospitalization and emergency room visits for patients with moderate COVID-19.” Data show that “of the total 30...